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PHigh Fat/High Carbohydrate Diet
nduces Aortic Valve Disease in C57BL/6J Mice
arie-Claude Drolet, MS,* Elise Roussel, MS,* Yves Deshaies, PHD,† Jacques Couet, PHD,*
arie Arsenault, MD*
ainte-Foy, Québec, Canada
OBJECTIVES The purpose of this study was to compare aortic valve function and morphology in adult
wild-type (WT) mice and in low-density lipoprotein receptor-deficient (LDLr/) mice fed
or not fed a high-fat/high-carbohydrate (HF/HC) diet.
BACKGROUND Observations suggest a link between degenerative aortic valve stenosis (AS) and atheroscle-
rosis. Aortic valve stenosis has been successfully induced in animal models of extreme
hypercholesterolemia, but these models are less relevant to humans. It is not known if a
proatherogenic HF/HC diet without added cholesterol could have the same negative impacts.
METHODS Forty C57BL/6J mice were divided into four groups: WT  normal diet, WT  HF/HC
diet, LDLr/ with a normal diet, and LDLr/ with a HF/HC diet. Aortic valve
function and histology were evaluated by echocardiography after four months.
RESULTS Wild-type mice on a HF/HC diet became mildly hypercholesterolemic, obese, and hyper-
glycemic. As expected, LDLr/mice became severely hypercholesterolemic. Both WT and
LDLr/ mice on a HF/HC diet displayed smaller valve areas and higher transvalvular
velocities (p  0.01) after four months. Aortic valve leaflets were thicker and infiltrated with
lipids and macrophages in both HF/HC groups.
CONCLUSIONS A HF/HC diet in mice results in significant aortic valve abnormalities. Putting WT mice on
a HF/HC diet reproduced a combination of atherogenic factors (obesity, mild dyslipidemia,
and hyperglycemia) more commonly encountered in humans than isolated severe hypercholes-
terolemia. Severe hypercholesterolemia was not a prerequisite in our model. This experimental
model suggests that AS development is multifactorial and that hypercholesterolemia should
not be the only target in this disease. (J Am Coll Cardiol 2006;47:850–5) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.049American College of Cardiology Foundation
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Degenerative calcific aortic valve stenosis (AS) is the most
ommon valvular heart disease potentially leading to valve
eplacement in North America. Recent observations have
uggested a link between AS and atherosclerosis. Many
raditional atherogenic factors, such as hypercholesterol-
mia, obesity, and diabetes, have been associated with a
igher prevalence of AS (1–3). Therefore, many investiga-
ors now focus on the hypothesis of an atherosclerosis-AS
ink. Hypercholesterolemia has been recurrently incrimi-
ated as a risk factor for developing AS. Cholesterol-
owering drugs (statins) are currently under investigation in
rospective trials evaluating their potential to alter AS
rogression (4–7).
Investigators have tried to reproduce AS in animal
odels of atherosclerosis. We and others have reported
ignificant aortic valve abnormalities in a classic experimen-
al atherosclerosis model (cholesterol-fed New Zealand
abbit) (8–11). This model of extremely severe hypercho-
esterolemia leads to characteristic atherosclerosis-like le-
ions in the aortic valve leaflets. This type of animal model
emains very useful but such high levels of blood cholesterol
From the *Groupe de recherche en valvulopathies, Institut de cardiologie de
uébec, and the †Département d’anatomie et de physiologie, Faculté de médecine,
entre de recherche Hôpital Laval, Université Laval, Sainte-Foy, Québec, Canada.
his work was supported by grants from the Heart and Stroke Foundation of Canada
nd from the Quebec Heart Institute. Jacques Couet and Marie Arsenault are scholars
rom the Fonds de la recherche en santé du Québec.(
Manuscript received June 30, 2005; revised manuscript received September 16,
005, accepted September 26, 2005.re rarely if ever encountered in humans. Considering that
S has been statistically associated with milder metabolic
bnormalities in human retrospective studies, we hypothe-
ized that a less aggressive atherogenic diet, without high
holesterol contents, could significantly alter the aortic
alve. The current study was therefore designed to assess if
high-fat/high-carbohydrate (HF/HC) diet (12) without
dded cholesterol can alter aortic valve function and mor-
hology in mice.
ETHODS
nimals. C57Bl/6J mice, which are genetically prone to
evelop diet-induced obesity and atherosclerotic lesions,
ere chosen for this protocol. Forty adult male (20 to 25 g),
ild type (WT) or low-density lipoprotein receptor
eficient (LDLr/ (C57BL/6J background) (Jackson
aboratories, Bar Harbor, Massachusetts), were divided
nto four groups (10 animals/group): group 1: WT 
ormal diet (used as normal controls); group 2: WT 
F/HC diet; group 3: LDLr/  normal diet; and
roup 4: LDLr/  HF/HC diet. All animals were
ollowed for four months. This protocol was made in
ccordance with the recommendations of the Canadian
ouncil for Animal Care and was approved by the local
nimal protection committee.
iets. Normal diet consisted of normal mouse chowMouse Colony Chow #5018; Purina Mills, St. Louis,
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February 21, 2006:850–5 Aortic Stenosis in Miceissouri). The HF/HC diet was purchased from BioServ
F3282; Frenchtown, New Jersey). In this HF/HC diet,
9% of total calories are provided from fats (high palmitic
cid content) without added cholesterol. Both diets were
vailable to the animals without restriction.
ata collection. At the end of protocol, mice were fasted
vernight, anesthetized with ketamine/xylazine, had an
chocardiogram (see the following section), and were there-
fter killed by exsanguination. Heart, lungs, livers and
bdominal fat were rapidly collected, weighed, and snap
rozen in liquid nitrogen for further analysis. Blood samples
ere taken for the measurement of fasting total choles-
erol, glucose, and insulin levels. Plasma levels of TNF-
lpha and interleukin-6 were also evaluated using specific
ouse enzymatic immunoassays (Assay Designs, Ann Ar-
or, Michigan).
chocardiography. A two-dimensional and Doppler
chocardiogram was performed at baseline and two months
nd just before death at four months under ketamine/
ylazine anesthesia. Ultrasound images were obtained with a
2-MHz phased-array probe connected to a Sonos 5500
chograph (Philips Medical Imaging, Andover, Massachu-
etts). Aortic valve area (AVA) was measured by continuity
quation. Parasternal long axis view was used to measure the
iameter of the left ventricular outflow tract as well as to
bserve the morphology and opening of the aortic leaflets.
istology. At death, a portion of the ascending aorta includ-
ng the aortic valve was dissected, rinsed in phosphate-buffered
aline, fixed in paraformaldehyde, and mounted in paraffin.
ross-sectional serial sections were prepared and von Kos-
a’s silver stain used to visualize calcium deposits.
ortic valve leaflet thickness. Good-quality leaflet sec-
ions of each group (n  5/group) were selected, and leaflet
hickness (middle portion) was measured using an image
nalysis software (SigmaScan, Systat Software, Point Rich-
ond, California) by an investigator blinded to the treat-
ent group. Normal leaflets (WT  normal diet [group 1])
Table 1. Animal Characteristics After Four M
WT
Normal H
Body weight, g 41.2  1.2 55
Heart weight, mg 148  2 1
Lung weight, mg 190  13 1
Liver weight, mg 1,575  84 2,5
Results are expressed as mean  SEM. Statistical analysi
Abbreviations and Acronyms
AS  aortic valve stenosis
AVA  aortic valve area
HF/HC  high fat/high carbohydrate
LDLr/ low-density lipoprotein receptor-deficient
WT  wild typecorresponding group on normal diet; †p  0.05 vs. WT on norma
WT  wild type; LDLr/  low-density lipoprotein-deficieere used as controls and the leaflet thickness of this group
as arbitrarily set at 100%.
mmunohistochemistry. The Vectastain system (Vector
aboratories, Burlingame, California) was used for immu-
ostaining. Monoclonal mouse anti-CD68 antibodies
NeoMarkers, Fremont, California) were used, followed by a
econdary peroxidase-conjugated rabbit antimouse antibody
or the identification of macrophage cells. Labeling for os-
eopontin (Clone 1B20, Assay Designs) and T-lymphocytes
anti-CD3, clone UCHT1; Dako Diagnostics Inc., Missis-
auga, Ontario, Canada) were performed similarly.
tatistics. Results are presented as mean  SEM unless
pecified otherwise. Repeated measures one-way analysis of
ariance with post-hoc Tukey test was used for intragroup
omparisons over time, and standard one-way analysis with
ost-hoc Tukey test was used for intergroup comparison.
npaired t test was used for comparisons between two
roups. Statistical significance was set at p  0.05.
ESULTS
nimal characteristics (Table 1). The LDLr/mice on
normal diet did not gain any weight during the protocol
nd therefore remained significantly smaller than all the
ther groups. Their heart, lung, and liver weights behaved
ccordingly and remained smaller.
All animals on the HF/HC diet (both WT and
DLr/) were significantly overweight compared to WT
normal diet. At death, total heart weight as well as liver
eight was significantly increased in both WT and
DLr/ on a HF/HC diet. Intra-abdominal fat was
ncreased by a mean of 60% in WT  HF/HC diet
ompared to WT  normal diet (p  0.01).
asting cholesterol, glucose, and insulin levels (Table 2).
ompared to WT  normal diet, cholesterol levels were
ildly elevated in WT  HF/HC diet to levels comparable
o LDLr/  normal diet and extremely elevated in
DLr/  HF/HC diet (p  0.01 vs. all other groups).
he LDL cholesterol levels were increased by the HF/HC
iet in normal animals, but these levels remained relatively
ow. As expected, LDL levels in LDLr/ animals were
igher than in WT animals.
Fasting glucose and insulin levels remained similar to
ontrols in the WT animals fed with the HF/HC diet.
nsulin levels tended to be slightly lower in this HF/HC
s on Normal or HF/HC Diet
LDLr/
C Normal HF/HC
2.0* 28.2  0.6† 50.8  2.3*
8* 122  2† 166  5*
14 147  3† 175  6
209* 1,062  47† 1,866  192*
-way ANOVA with post-hoc Tukey test. *p  0.05 vs.onth
F/H
.9 
82 
88 
33 
s: one
l diet.
nt mice; HF/HC  high-fat/high-carbohydrate diet.
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Aortic Stenosis in Mice February 21, 2006:850–5roup (p  NS). Fasting blood glucose levels were signifi-
antly higher than normal reported values for fasting glucose
n normal mice in both WT groups. Insulin levels were
ithin normal reported values. Both LDLr/ groups had
ery high blood glucose levels combined with severely
ecreased insulin levels compatible with overt diabetes
ellitus with decreased insulin production.
ediators of inflammation. Inflammatory mediators
nterleukin-6 and TNF-alpha were measured and remained
ow, without any significant difference between normal and
F/HC diets in WT mice.
chocardiographic assessment. Aortic valve leaflets were
ore echogenic after four months in all groups compared
ith WT  normal diet. Aortic valve area was significantly
maller in all groups compared with WT  normal diet.
onsidering the large differences in body weight between
roups, valve area was indexed for body weight as shown in
able 3. Once corrected for body weight, valve area in
DLr/ with normal diet group was not reduced and
emained comparable to WT  normal diet. Only animals
n a HF/HC diet, WT and LDLr/, had smaller valve
reas despite correction for body weight. Similar results
ere found for maximal transvalvular velocities. Only ani-
als on the HF/HC diet displayed increased transvalvular
elocities. Figures 1A and 1B shows the parallel evolution of
VA and body weight over time during the four-month
rotocol in WT animals. In the WT  normal diet, both
ody weight and AVA increased during the course of the
rotocol, whereas the HF/HC animals gained more weight
nd their AVA remained unchanged. Increases in transval-
ular velocities became significant after two to four months
n the HF/HC diet (Fig. 1C). Typical examples of trans-
able 2. Serum Cholesterol, LDL, Glucose, and Insulin Levels A
WT
Normal
otal cholesterol, mmol/l (mg/dl) 2.52  0.23 (97) 4.30
DL-cholesterol, mmol/l (mg/dl) 0.15  0.012 (5.8) 1.18
lucose, mmol/l (mg/dl) 14.4  1.0 (260) 14.9
nsulin, pmol/l (IU/ml) 212  35 (31) 166
lucose/insulin ratio 0.09  0.021 0.16
ata are presented as mean SEM (n 10). Statistical analysis: one-way ANOVA wit
iet.
Abbreviations as in Table 1.
Table 3. Echocardiographic Evaluation of Aor
or HF/HC Diet
WT
Normal H
AVA (mm2) 1.62  0.07 1.
AVAi (mm2/mg) 39.3  1.2 21
Max vel (cm/s) 83.6  1.5 108
Results are expressed as mean  SEM. Statistical analysis: o
normal diet; †p  0.05 vs. LDLr/  normal diet.AVA  aortic valve area; AVAi  AVA indexed for body
continuous-wave Doppler; other abbreviations as in Table 1.alvular velocities in WT on normal (top panel) and
F/HC (bottom panel) diets are shown in Figure 2.
eaflet thickness (Fig. 3). Leaflet thickness was signifi-
antly increased in WT mice fed with the HF/HC diet
ompared with the WT normal diet. A typical example of
eaflet thickening in the WT  HF/HC diet group is
llustrated in Figure 4. Similar observations were made in
DLr/  HF/HC group (not shown).
mmunohistochemistry (Fig. 4). Macrophage infiltration
CD68-positive cells) and foam cells were clearly evident in
he thickened valve leaflets of the animals in groups fed with
he HF/HC diet. Osteopontin expression and
-lymphocyte infiltrates were also detected (not shown) as
ell as some nodular calcium deposition by von Kossa’s
tain.
ISCUSSION
e report for the first time in an animal model that aortic
alve disease can be initiated by a high-fat/high-
arbohydrate diet. Contrary to previously published animal
odels of the disease which were exclusively associated with
evere hypercholesterolemia, we demonstrate in this study
hat a HF/HC diet with a low cholesterol content not only
esults in mild dyslipidemia, obesity, and hyperglycemia in
hese mice but also induces significant aortic valve abnor-
alities both in vivo (smaller valve area and higher trans-
alvular velocities) and ex vivo (leaflet thickening, lipid and
acrophage infiltrates, signs of calcification). The abnor-
alities found in the valves of the animals closely resemble
hose found in the early phases of AS (13,14).
Numerous epidemiologic and histologic studies have
uggested a link between proatherogenic factors and AS
Four Months
LDLr/
HC Normal HF/HC
1 (166)* 6.37  0.26 (246)* 18.74  2.26 (722)*†
89 (45.5)* 3.17  0.359 (122.5)* 9.15  1.531 (353.1)*†
(268) 23.6  1.3 (425)* 28.6  1.0 (515)*†
(24) 15  2 (2)* 48  14 (7)*†
55 1.88  0.327* 0.91  0.178*
hoc Tukey test. *p 0.05 vs. WT normal diet; †p 0.05 vs. LDLr/ normal
alve in Vivo After Four Months of Normal
LDLr/
C Normal HF/HC
0.07* 1.02  0.05* 1.16  0.06*
0.9* 36.2  1.6 24.0  1.6*†
7.4* 79.2  2.1 99.8  3.7*†
y ANOVA with post-hoc Tukey test. *p  0.05 vs. WT fter
HF/
 0.4
 0.0
 1.7
 40
 0.0
h post-tic V
F/H
22 
.8 
.1 
ne-waweight; Max Vel  maximal transvalvular velocities by
(
l
h
s
H
A
l
d
p
o
b
t
a
h
m
r
o
T
a
s
a
F
c
(
t
p
b
0
F
w
(
F
c
853JACC Vol. 47, No. 4, 2006 Drolet et al.
February 21, 2006:850–5 Aortic Stenosis in Mice1,15,16). High LDL, low high-density lipoprotein, high
ipoprotein(a), cigarette smoking, obesity, diabetes mellitus,
ypertension, and high C-reactive protein have all been
hown to be statistically associated with AS (3,5,6,17–22).
ypercholesterolemia has been recurrently associated with
S in epidemiologic and histologic studies. Low-density
ipoprotein deposits in the diseased leaflets have been clearly
emonstrated (23). In order to better understand the patho-
hysiology of the disease and its link with hypercholester-
lemia, animal models of aortic valve sclerosis/stenosis have
een developed (9–11,24). It has clearly been shown in
hese models of extreme severe hypercholesterolemia that
igure 1. Aortic valve area (AVA) (open circles) and body weight (closed
ircles) evolution during the study in wild-type mice fed with a normal diet
A) or a high-fat/high-carbohydrate (HF/HC) diet (B). (C) Maximal
ransvalvular velocities (cm/s) over time during the study. Results are
resented as mean  SEM. *p  0.05; **p  0.01 vs. baseline (month 0)
y repeated measures analysis of variance with Tukey post-hoc test. ##p 
.01 between indicated values by unpaired t test.ortic leaflet lesions sharing similarities with those found in
a
tumans can be reproduced (9–11). However the develop-
ent of AS in severely hypercholesterolemic animals is not
eminiscent of the human disease, because such high levels
f cholesterol are rarely (if ever) encountered in humans.
hese animal models remain very useful research tools but
re clearly imperfect.
Treatment of hypercholesterolemia to slow the progres-
ion of AS remains controversial. Despite a clear statistical
ssociation in retrospective studies, a recently published
igure 2. Typical examples of maximal transvalvular aortic velocities in
ild-type mice fed with normal diet (top) or high-fat/high-carbohydrate
HF/HC) diet (bottom) by continuous-wave Doppler.
igure 3. Leaflet thickness in wild-type mice fed with high-fat/high-
arbohydrate (HF/HC) diet vs. normal diet. Results are expressed in
rbitrary units (AU) with normal leaflet thickness set at 100. An unpaired
test was used for the statistical comparison.
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Aortic Stenosis in Mice February 21, 2006:850–5rospective trial using a statin has yielded negative results
25). Aortic valve stenosis is clearly a frequent disease in
orth America, and proatherogenic factors that have been
tatistically linked with AS are closely related to the North
igure 4. Increased aortic valve leaflet (arrows) thickness in wild-type
ouse fed a high-fat/high-carbohydrate (HF/HC) diet (middle) compared
ith normal diet (top). Leaflets in HF/HC animals show positive labeling
or macrophages (CD68-positive cells) and foam cells (arrows). Inset
middle section) shows a magnified view of the diseased leaflet. Bottom
anel shows calcium deposits (arrow) in an aortic valve leaflet of an
F/HC diet-fed wild-type mouse by von Kossa’s stain.merican lifestyle. Hypercholesterolemia is only one of these factors. For these reasons, we evaluated if exposure to
“North American diet” consisting of high amounts of
oncholesterol fats and carbohydrates could induce signifi-
ant abnormalities in the aortic valve. In our WT animals,
his diet induced abdominal obesity, mild hypercholesterol-
mia, and hyperglycemia. This is more reminiscent of the
lassic atherogenic factors found in North America. This
ombination of metabolic abnormalities in our animals also
hares striking similarities with the human metabolic syn-
rome (26).
Considering that known animal models of the disease
ere related to severe hypercholesterolemia we also wanted
o assess if this was a prerequisite for the development of
ortic valve lesions. We therefore compared WT mice with
utants deficient in LDL receptors. Our results show that
ortic valve abnormalities are found in both groups on the
F/HC diet even though the two groups had very different
DL cholesterol levels. Despite this striking difference in
holesterol levels, animals in both groups had decreased
VA and similar increases in transvalvular velocities after
our months on the HF/HC diet. These results suggest that
evere hypercholesterolemia is not a prerequisite to induce
ortic valve disease in those mice. It also suggests that a
ombination of milder hypercholesterolemia with other
therogenic risk factors such as abdominal obesity and
yperglycemia may be enough to initiate the process. The
orst combination of atherogenic factors capable of induc-
ng the most severe and progressive aortic valve abnormal-
ties in this animal model remains to be determined.
owever, our results clearly point toward a multifactorial
tiology.
tudy limitations. The current study was short-term (four
onths). It is possible that LDLr/mice on normal diet
ad mild valve abnormalities that would have become
ore evident after a longer follow-up. The speed of
rogression of the disease was not assessed and we do not
now if the animals with the most atherogenic factors
ould have progressed faster toward a more severe aortic
alve disease. Blood pressure was not measured. Some
nimals might have developed some degree of hypertension,
hich has been previously linked to AS.
onclusions. We report for the first time the development
f aortic valve disease in obese, mildly hypercholesterolemic,
yperglycemic mice resulting from exposure to a high-fat/
igh-carbohydrate diet without added cholesterol. We have
eproduced the early stage of aortic valve disease in this
nimal model in association with a mix of atherogenic risk
actors more frequently encountered in humans in North
merica and sharing similarities with the human metabolic
yndrome.
cknowledgment
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